Efficacy and tolerability of perampanel as add‐on therapy in Dravet syndrome: A prospective real‐world study
Sign Up to like & getrecommendations! Published in 2025 at "Epilepsia Open"
DOI: 10.1002/epi4.70058
Abstract: To investigate the efficacy and tolerability of perampanel (PER) on Dravet syndrome in China by a prospective real‐world study. read more here.
Keywords: dravet syndrome; tolerability perampanel; efficacy tolerability; world study ... See more keywords
Real-World Study of Multiple Naloxone Administrations for Opioid Overdose Reversal among Emergency Medical Service Providers
Sign Up to like & getrecommendations! Published in 2022 at "Substance Abuse"
DOI: 10.1080/08897077.2022.2060433
Abstract: Background: The increasing rates of highly potent, illicit synthetic opioids (i.e., fentanyl) in the US is exacerbating the ongoing opioid epidemic. Multiple naloxone administrations (MNA) may be required to successfully reverse opioid overdoses. We conducted… read more here.
Keywords: multiple naloxone; opioid overdose; naloxone administrations; world study ... See more keywords
Real-world study of isavuconazole adverse events based on pharmacovigilance spontaneous reporting systems.
Sign Up to like & getrecommendations! Published in 2024 at "Expert opinion on drug safety"
DOI: 10.1080/14740338.2024.2444579
Abstract: BACKGROUND Isavuconazole is a novel second-generation triazole antifungal agent.We conducted a retrospective investigation to analyze the occurrence of adverse events (AEs) associated with isavuconazole in real-world clinical use by data-mining self-reporting databases, aiming to provide… read more here.
Keywords: adverse events; world study; real world; isavuconazole adverse ... See more keywords
Clinical efficacy of tacrolimus in systemic lupus erythematosus with various manifestations: a real-world study
Sign Up to like & getrecommendations! Published in 2022 at "Chinese Medical Journal"
DOI: 10.1097/cm9.0000000000002302
Abstract: To the Editor: Systemic lupus erythematosus (SLE) is an treated with tacrolimus and followed up at 3 months or autoimmune disease involving multiple systems. In recent years, the therapeutic treat-to-target (T2T) strategy was recommended for… read more here.
Keywords: systemic lupus; world study; lupus erythematosus; lupus ... See more keywords
Real‐world study of treatment and outcome of type B2 + B3 thymoma: The neglected part of thymoma
Sign Up to like & getrecommendations! Published in 2023 at "Thoracic Cancer"
DOI: 10.1111/1759-7714.14875
Abstract: This study aimed to examine the treatment and prognosis of patients with type B2 + B3 thymoma and compare it with those patients with type B2 and B3 thymoma. read more here.
Keywords: thymoma; world study; treatment; real world ... See more keywords
Efficacy and safety of utidelone in pretreated patients with metastatic breast cancer in China: a multicenter, real-world study
Sign Up to like & getrecommendations! Published in 2025 at "Therapeutic Advances in Medical Oncology"
DOI: 10.1177/17588359251368684
Abstract: Background: Utidelone (UTD1), a genetically engineered epothilone derivative, has been approved in China for use in combination with capecitabine in treating metastatic breast cancer (MBC) patients previously treated with anthracyclines or taxanes. Objectives: To evaluate… read more here.
Keywords: breast cancer; world study; real world; metastatic breast ... See more keywords
Real-world study of children and young adults with myeloproliferative neoplasms: identifying risks and unmet needs
Sign Up to like & getrecommendations! Published in 2022 at "Blood Advances"
DOI: 10.1182/bloodadvances.2022007201
Abstract: Key Points In a contemporary cohort of 444 young MPN patients, risks of thrombosis, hemorrhage, and transformation were 1% pt/y. Current risk scores had no utility. Uniquely, we identify that splenomegaly and hyperviscosity symptoms predict… read more here.
Keywords: adults myeloproliferative; young adults; real world; world study ... See more keywords
CASSIOPE: A real-world study assessing the use of cabozantinib for the treatment of advanced renal cell carcinoma (aRCC) after vascular endothelial growth factor (VEGF)-targeted therapy in Europe.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2020.38.6_suppl.tps770
Abstract: TPS770Background: Cabozantinib, an inhibitor of multiple receptor tyrosine kinases including VEGF receptor 2, and MET and AXL receptors, is approved for the treatment of aRCC in the USA and, in Eur... read more here.
Keywords: real world; world study; cassiope real; treatment ... See more keywords
Safety, immunogenecity and effectiveness of ChAdOx1 nCoV-19 vaccine during the second wave of pandemic in India: a real-world study
Sign Up to like & getrecommendations! Published in 2023 at "Drug Metabolism and Personalized Therapy"
DOI: 10.1515/dmpt-2022-0150
Abstract: Abstract Objectives This real-world study was conducted to assess the adverse effects following immunization (AEFI) and immunogenicity of ChAdO×1 nCoV-19 vaccine in terms of neutralising antibody titers and to study the effects of covariates such… read more here.
Keywords: chadox1 ncov; infection; antibody titers; world study ... See more keywords
Dolutegravir plus Lamivudine as initial therapy for HIV-1 Infected and ARV-naive Patients in West China, 24-Weeks results of a preliminary real-world study.
Sign Up to like & getrecommendations! Published in 2022 at "Current HIV research"
DOI: 10.2174/1570162x20666220514165728
Abstract: INTRODUCTION This preliminary real-world study (RWS) was designed to evaluate the antiviral efficacy, safety, and feasibility of the 2-drug regimen (2DR), dolutegravir plus lamivudine as the initial antiretroviral therapy (ART) among antiretroviral (ARV)-naïve adults with… read more here.
Keywords: hiv; world study; hiv rna; west china ... See more keywords
Ocrelizumab in Multiple Sclerosis: A Real-World Study From Spain
Sign Up to like & getrecommendations! Published in 2020 at "Frontiers in Neurology"
DOI: 10.3389/fneur.2020.592304
Abstract: Objectives: The aim of this study was to describe the tolerability, safety, and effectiveness of ocrelizumab for primary progressive multiple sclerosis (PPMS) and relapsing multiple sclerosis (RMS) in a clinical practice setting. Methods: In this… read more here.
Keywords: real world; multiple sclerosis; world study; study ... See more keywords